Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology

BACKGROUND: Binge-eating disorder (BED) is a common psychiatric condition with adverse psychological and metabolic consequences. Lisdexamfetamine (LDX) is the only approved BED drug treatment. New drugs to treat BED are urgently needed. METHODS: A comprehensive review of published psychopathological...

Descripción completa

Detalles Bibliográficos
Autores principales: Heal, David J, Smith, Sharon L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150143/
https://www.ncbi.nlm.nih.gov/pubmed/34318734
http://dx.doi.org/10.1177/02698811211032475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150143/
https://www.ncbi.nlm.nih.gov/pubmed/34318734
http://dx.doi.org/10.1177/02698811211032475

Ejemplares similares